Last September, the New Hampshire legislature voted to allow the Department of Health & Human Services to restrict access to drugs in the Medicaid program through the use of a preferred drug list (PDL). Once the list is established, only prescribed drugs on the list will be available automatically. To obtain a drug not on the list, consumers and their physicians will need prior permission. Getting permission can be a burden to the consumer, family and physician.
The legislature authorized use of a PDL as a cost-saving measure ONLY if three patient protections are in place (House Bill 4). The protections are:
SB 383 threatenes all three of these important patient protections, although the House did insert amendments that appear to protect some of the provisions. It is now up to the Senate to decide and vote on this bill. Advocates should ask Senators to (1) Vote NO on SB 383, or if they must vote in favor of this bill, (2) Keep the amendments inserted by the House of Representatives currently in the legislation in place.
Please contact your Senator and ask them to vote to kill SB 383 or to keep the House Amendments in SB 383 in place.